SEC Form 4 · accession 0000950142-15-001469
Zeltiq Aesthetics Inc · ZLTQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew N Schiff
Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 22, 2015 · 8:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 17, 2015 | A | 4,996 | $0.00 | A | 6,148 | D | |
| Common StockF4 | holding | — | — | — | 2,597,742 | I | By Aisling Capital III, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "Common Stock"). The restricted stock units vest in 12 ratable monthly installments hereafter, subject to Mr. Schiff's continued service with the Issuer, and upon vesting Mr. Schiff receives shares of Common Stock.
- F2Issued pursuant to the 2011 Equity Incentive Plan of the Issuer.
- F3Includes 87 shares of Common Stock held by a trust for the benefit of Mr. Schiff's children.
- F4The shares are directly held by Aisling Capital III, LP ("Aisling") and are indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III, LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Andrew Schiff is a member of the Board of Directors of Zeltiq Aesthetics, Inc.